| Author (Corporate) | European Commission: DG Communication |
|---|---|
| Series Title | Press Release |
| Series Details | IP/12/1075 (05.10.12) |
| Publication Date | 05/10/2012 |
| Content Type | News |
|
The European Commission has cleared under the EU Merger Regulation the proposed acquisition of the Swiss-based pharmaceutical company Actavis by the generic pharmaceutical company Watson of the U.S. The Commission concluded that the merged entity will continue to face a number of strong competitors. |
|
| Source Link | Link to Main Source http://europa.eu/rapid/pressReleasesAction.do?reference=IP/12/1075&format=HTML&aged=0&language=EN&guiLanguage=en |
| Subject Categories | Internal Markets |
| Countries / Regions | Europe |
